Results 171 to 180 of about 216,694 (240)

Immunogenicity of Hepatitis B Virus Vaccination in Relapsing-Remitting Multiple Sclerosis Patients Under Immunocompromising Treatment. [PDF]

Int J Mol Sci
Cruces-Párraga J, Muñoz-Jurado A, Escribano BM, Martín-Hersog FA, Triguero-Ortiz C, Carmona-Medialdea C, Túnez I, Caballero-Villarraso J, Agüera-Morales E.   +8 more
europepmc   +1 more source

Relapsing-Remitting Multiple Sclerosis Is Associated With a Dysbiotic Oral Microbiome. [PDF]

Ann Clin Transl Neurol
Ganesan SM, Yadav M, Ghimire S, Lehman PC, Patel AJ, Woods S, Olalde H, Hoang J, Paullus M, Cherwin C, Gill C, Cho T, Mangalam AK.   +12 more
europepmc   +1 more source

Comparative Effectiveness and Safety of Rituximab Versus Ocrelizumab in Relapsing-Remitting Multiple Sclerosis: A Finnish Population-Based Matched Cohort Study. [PDF]

Eur J Neurol
Savolainen M, Soilu-Hänninen M, Nurmi H, Viitala M, Tienari P, Atula S, Laakso SM.   +6 more
europepmc   +1 more source

Siponimod for relapsing-remitting multiple sclerosis: a single-center, real-world cohort study in China. [PDF]

BMC Neurol
Tan H, Zhou L, Gao Y, Zhao C, Lu C, Dong Q, ZhangBao J, Quan C.   +7 more
europepmc   +1 more source

A potential of serum anti-C1P IgG antibodies as biomarkers in differential diagnosis of relapsing-remitting multiple sclerosis. [PDF]

Sci Rep
Chojdak-Lukasiewicz J, Jakubiak-Augustyn A, Szulc ZM, Gubernator J, Blazej P, Pokryszko-Dragan A, Budrewicz S, Podbielska M.   +7 more
europepmc   +1 more source

Twenty-Four-Month Real-World Outcomes of Ofatumumab in Relapsing-Remitting Multiple Sclerosis: A Multicenter Retrospective Cohort Study. [PDF]

J Clin Med
Galus W, Kiełbowicz-Hołysz M, Siuda J, Gajewska G, Lasek-Bal A, Puz P.   +5 more
europepmc   +1 more source

Functional Training Mitigates Reduced Circulating Indole-3-Lactate Levels in Persons With Relapsing-Remitting Multiple Sclerosis. [PDF]

Acta Physiol (Oxf)
Wences Chirino T, Adammek F, Belen S, Winker M, Proschinger S, Rademacher A, Schlagheck ML, Schenk A, Kupjetz M, Walzik D, Warnke C, Reuter M, Rosenberger F, Meyer T, McCann A, Ueland PM, Joisten N, Zimmer P.   +17 more
europepmc   +1 more source

Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysis.

Cochrane Database of Systematic Reviews, 2015
I. Tramacere, C. Del Giovane, G. Salanti, R. D'amico, G. Filippini   +4 more
semanticscholar   +1 more source

Personalizing Relapsing-Remitting Multiple Sclerosis Monitoring: Patient Acceptance of Serum Neurofilament Light Chain and the Role of Disease Knowledge. [PDF]

J Pers Med
Pérez-Sempere Á, García-Arcelay E, Pérez JC, Candeliere-Merlicco A, Orviz A, Martín-Martínez J, Piñar-Morales R, Álvarez-Rodríguez E, Pacheco-Cortegana EM, Borrega L, Casanova I, Caminero AB, Sánchez-Menoyo JL, Gómez-Gutiérrez M, Carmona O, Calles C, Hernández MÁ, López-Muñoz P, Bakdache F, Monreal E, González-Suárez I, Maurino J.   +21 more
europepmc   +1 more source